Choosing ImmunotherapyVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
How to Foster Communication Among all Members of the Cancer Care Team with Pathologists to Deliver Individualized Treatment for Patients with Lung Cancer
Drs Roy Herbst and David Rimm consider novel ways that surgeons, interventional radiologists, pulmonologists, medical oncologists, and pathologists interact at Yale Cancer Center to maximize the use of common molecular biomarkers, as well as NGS and TMB, in providing precision medicine to lung cancer patients.
Dr Andrey Antov believes it’s important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.